ArticleInternational journal of hematology2022

Safety profile of bosutinib in Japanese versus non-Japanese patients with chronic myeloid leukemia: a pooled analysis.

Naoto Takahashi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.